You may feel like you’re going to die — but you’re not. Your body is right here in this safe place and we are monitoring you ...

A new study shows longer-term use of generic ketamine for severe depression is safe and effective, but researchers say access to the low-cost option remains limited by funding gaps.

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

Electroconvulsive therapy (ECT) appears to be far more effective than algorithm-based drug therapy for treatment-resistant bipolar depression in what is believed to be the first randomized, controlled ...

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression - making it the first FDA-approved oral pill in the United States specifically for ...

Read A Biblical Path through Treatment-Resistant Depression by Dr. Audrey Davidheiser and more articles about PLUS on ...

The U.S. Food and Drug Administration (FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.

Ketamine is increasingly being used as an off-label treatment for depression, but researchers have found it might not provide ...

Finasteride, a common hair-loss drug, has long been tied to depression and suicide, but regulators ignored the warnings. Prof ...